Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-PANC
NCT07748611Phase 2Recruiting
- Sponsor
- Northwestern University
- Start
- Oct 2026
- Primary completion
- Feb 2030
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, paclitaxel in pancreatic ductal adenocarcinoma (PDAC), sponsored by Northwestern University. Started Oct 2026; status: recruiting.
02
Drugs
gemcitabinepaclitaxel
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT07748611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748611.